Text Size
20 studies found for:    MAO-B

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Terminated MOTION, Safinamide in Early Idiopathic Parkinson's Disease (IPD), as add-on to Dopamine Agonist (Extension of Trial 27918)
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Safinamide, MAO-B inhibitor;   Drug: Placebo
2 Recruiting A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy Volunteers
Condition: Healthy Volunteer, Alzheimer Disease
Interventions: Drug: RO4602522;   Drug: 11C-L-deprenyl-D2
3 Completed Multi Dose Effects of a Berry Extract Upon Moodand Cognition in Healthy Young Adults
Condition: Healthy
Intervention: Dietary Supplement: Fresh berry extract.
4 Completed Open-Label Trial to Determine the Long-Term Safety of Safinamide in Parkinson's Disease Patients
Condition: Parkinson's Disease
Intervention: Drug: Safinamide
5 Completed Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
Condition: Idiopathic Parkinson's Disease
Interventions: Drug: Safinimide 50-100 mg/day;   Drug: Matching Placebo
6 Unknown † The Effects of Rasagiline on Cognitive Deficits Associated With Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: placebo;   Drug: rasagiline
7 Completed Efficacy of Orally Disintegrating Selegiline in Parkinson's Patients Experiencing Adverse Effects With Dopamine Agonists
Condition: Parkinson's Disease
Intervention: Drug: orally disintegrating selegiline (Zelapar)
8 Completed Physiological, Cognitive and Cerebral Activity Changes as a Function of Cigarette Smoking (With or Without Nicotine) and Tobacco Abstinence
Condition: Smoking Cessation
Intervention:
9 Not yet recruiting Effects of Rasagiline on Sleep Disturbances in Parkinson's Disease
Conditions: Sleep Disturbances;   Parkinsons's Disease
Interventions: Drug: Rasagiline;   Drug: Placebo
10 Unknown † Rasagiline for Gait Treatment
Condition: Parkinson Disease
Intervention:
11 Not yet recruiting Evaluation of the Efficacy of Rasagiline in Apathy in Drug-naïve Patients With Parkinson's Disease by a Multi-center Study
Conditions: Drug-naïve Patients With Parkinson's Disease;   Apathy
Interventions: Drug: AZILECT®;   Drug: Placebo
12 Terminated Multicenter Placebo Controlled Study to Assess the Effect of Rasagiline on Sleep-wake Disturbances in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Rasagiline
13 Recruiting The Effect of Rasagiline on Cognition in Parkinson's Disease
Condition: Parkinson's Disease
Interventions: Drug: Rasagiline;   Drug: Placebo
14 Recruiting The Time Effects of a Berry Extract Upon Cerebral Blood Flow.
Condition: Cerebral Blood Flow
Interventions: Dietary Supplement: Berry drink;   Dietary Supplement: Control
15 Unknown † Effects of Chocolate on Motor Symptoms of Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Dietary Supplement: Chocolate
16 Completed Tolerability and Efficacy of Switch From Oral Selegiline to Orally Disintegrating Selegiline (Zelapar) in Patients With Parkinson's Disease
Condition: Parkinson's Disease
Intervention: Drug: Zelapar
17 Completed The Effect Of Berry Polyphenols On Human Behaviour
Condition: Healthy
Interventions: Dietary Supplement: Berry Polyphenols;   Dietary Supplement: Placebo
18 Completed MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist
Condition: Idiopathic Parkinson's Disease
Intervention: Drug: Safinamide (as add-on therapy)
19 Completed Phase II Study to Evaluate the Effectiveness of EVT 302 in Smoking Cessation.
Condition: Smoking Cessation
Interventions: Drug: EVT 302;   Drug: Placebo;   Drug: EVT 302 plus open label Nicotine replacement;   Drug: Placebo plus open label Nicotine Replacement
20 Active, not recruiting Contribution of Wine Components on Hydroxytyrosol Body Concentrations and Biological Effects
Condition: Contribution of Wine Components in Hydroxytyrosol Formation
Interventions: Dietary Supplement: Ethanol;   Other: Water;   Dietary Supplement: Alcoholized wine;   Dietary Supplement: De-alcoholized wine
To Top

† Indicates status has not been verified in more than two years